Match!
Neil J. Stone
Northwestern University
210Publications
40H-index
36.6kCitations
Publications 210
Newest
#1Vincent A. Pallazola (Johns Hopkins University)H-Index: 1
#2Dorothy M. Davis (Johns Hopkins University)
Last.Francine K. Welty (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 35
view all 0 authors...
Abstract Despite continued advances in health care, the cardiovascular disease (CVD) mortality rate has plateaued in recent years and appears to be trending upward. Poor diet is a leading cause of obesity and type 2 diabetes mellitus, which are leading contributors to CVD morbidity and mortality. Although dietary modification is a cornerstone of CVD prevention, implementation in clinical practice is limited by inadequate formal training in nutrition science. In this report, we review the individ...
#1Xiaoming Jia (BCM: Baylor College of Medicine)H-Index: 3
#2Mahmoud Al Rifai (Johns Hopkins University)H-Index: 10
Last.Salim S. ViraniH-Index: 36
view all 10 authors...
Abstract Background Measurement with a lipid panel after statin initiation and in long-term follow-up is recommended in both 2013 and 2018 cholesterol guidelines to assess statin efficacy and adherence. We assessed whether routine laboratory evaluation with lipid panels is associated with greater statin adherence. Methods We identified patients with atherosclerotic cardiovascular disease within the entire Veterans Affairs (VA) health care system with at least one primary care visit between Octob...
#1Daniel E. Forman (University of Pittsburgh)H-Index: 44
#2Neil J. Stone (NU: Northwestern University)H-Index: 40
Last.Scott M. Grundy (UTSW: University of Texas Southwestern Medical Center)H-Index: 168
view all 3 authors...
The 2018 American Heart Association/American College of Cardiology Multisociety Cholesterol Guidelines [(1)][1] recommend risk stratification among patients with atherosclerotic cardiovascular disease (ASCVD) to identify “very high-risk ASCVD patients.” These patients have characteristics
#1Kelly Arps (Johns Hopkins University)H-Index: 1
#2Vincent A. Pallazola (Johns Hopkins University)H-Index: 1
Last.John Wikstrand (Johns Hopkins University)H-Index: 62
view all 10 authors...
ABSTRACT Efforts to better control risk factors for cardiovascular disease and prevent the development of subsequent cardiovascular events are crucial to maintaining healthy populations. In today's busy practice environment and with the overwhelming pace of new research findings, ensuring appropriate emphasis and implementation of evidence-based preventive cardiovascular care can be challenging. The ABCDEF approach to cardiovascular disease prevention is intended to improve dissemination of cont...
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [‡‡‡][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD,
#1Kent Brummel (NU: Northwestern University)H-Index: 2
#2Nilay S Shah (NU: Northwestern University)H-Index: 1
Last.Neil J. Stone (NU: Northwestern University)H-Index: 40
view all 3 authors...
Abstract Lipid profiles help estimate patient's short and long-term atherosclerotic cardiovascular disease risk over the life course and inform treatment decisions. Advanced lipid testing can provide additional information in selected patients. New 2018 cholesterol guidelines suggest which patients may benefit from additional testing. In patients 40–75 years, calculation of a 10-year atherosclerotic cardiovascular disease risk score begins the clinician-patient risk discussion. In those at inter...
12345678910